Scientists at Queen’s University Belfast have discovered a new molecule which has the potential to prolong the life of individuals with cystic fibrosis (CF).
The molecule represents a possible future treatment and works by altering cellular ion channels resulting in improved airway hydration and significantly increased mucus clearance.
For individuals with CF, normal airway clearance mechanisms which keep the lungs free of infection are defective. As a result, a build-up of mucus occurs and predisposes the individual to chronic bacterial infection. The ensuing cycles of chronic infection and airway inflammation cause progressive destruction of the airways, which is ultimately fatal.
The innovative approach could reduce the frequency of these infections through a novel protease inhibitor which prevents activation of the epithelial sodium channel; ENaC.
The research involved a team of scientists from Queen’s University alongside colleagues at the Royal College of Surgeons in Ireland and the University of North Carolina, and was funded by The Cystic Fibrosis Trust.
Speaking about the breakthrough, Dr Lorraine Martin from the School of Pharmacy at Queen’s University Belfast, said: “This is an important finding which could provide a novel therapeutic opportunity relevant to all individuals with CF, as the targeting of ENaC is independent of their underlying CF mutation. This strategy could prevent the significant lung damage that results from chronic cycles of infection and inflammation, with potential impact on quality of life as well as life expectancy. This is a further example of Queen’s University’s research advancing knowledge and changing lives.”
Ed Owen, Chief Executive at the Cystic Fibrosis Trust, said: “We are thrilled with these initial findings and are excited to see how the next stage of preclinical testing progresses. We are pleased to have been able to fund this world class project at its early stage and welcome the drug development programme planned over the coming years. Research is the biggest single area of investment for the Cystic Fibrosis Trust and it’s wonderful to see projects like this making such positive progress in our fight for a life unlimited.”
Currently available pharmacological alternatives are only suitable for a small subset of patients depending on the disease-causing genetic mutation.
The Latest on: Cystic Fibrosis
via Google News
The Latest on: Cystic Fibrosis
- Study for better understanding of cystic fibrosison October 10, 2021 at 10:50 pm
According to Cystic Fibrosis Canada, CF is the most common fatal genetic disease affecting Canadian children and young adults. There is presently no c..
- Area hikers are top team in Xtreme Hike for Cystic Fibrosison October 10, 2021 at 5:15 pm
Culpeper-area hikers have been named the top fundraisers for Virginia’s 2020 Xtreme Hike for Cystic Fibrosis near Front Royal. Sleep Hikers won for the third year in a row, raising ...
- Woman runs Boston Marathon for cystic fibrosis patienton October 8, 2021 at 5:13 pm
CNBC's Perry Rossum joins Shep Smith to report on one woman who can't wait to cross the finish line at the Boston Marathon, for her patient.
- ‘Night and day’: Niagara patients and families rejoice at approval for cystic fibrosis drugon October 8, 2021 at 3:01 am
Ontario’s approval of the drug Trikafta to treat cystic fibrosis (CF) could change the lives of one St. Catharines family.
- Eloxx Pharmaceuticals to Host Investor and Analyst Call and Webcast on Cystic Fibrosis Programson October 7, 2021 at 1:15 pm
Globally renowned CF Expert, Dr. Eitan Kerem will provide key insights Data from ongoing Phase 2 trials in CF expected in 4Q 2021 WATERTOWN, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Eloxx ...
- Better understanding of cystic fibrosison October 6, 2021 at 7:11 pm
New understanding of cellular defects related to Cystic Fibrosis (CF) could help pave the way for treatment. Researchers at the University of Saskatchewan (USask) are hopeful new understanding of ...
- New research contributes to understanding of cystic fibrosison October 6, 2021 at 12:58 pm
Researchers at the University of Saskatchewan (USask) are hopeful new understanding of cellular defects related to cystic fibrosis (CF) could help pave the way for treatment of the disease.
- New USask research contributes to understanding of Cystic Fibrosison October 6, 2021 at 12:45 pm
Researchers at the University of Saskatchewan (USask) are hopeful new understanding of cellular defects related to Cystic Fibrosis (CF) could help pave the way for treatment of the disease. A team in ...
- B.C. to fund 'game changer' cystic fibrosis drug Trikaftaon October 6, 2021 at 9:16 am
Advocates in the cystic fibrosis community are celebrating after the B.C. government announced it will cover the high-cost treatment drug Trikafta. Jocelyn Joyce, who has an 18-year-old son with ...
- Inhaled Drug Could Treat Rare Cystic Fibrosis Mutationson October 5, 2021 at 1:02 pm
SpliSense can generate a functioning protein to replace one that is defective in 20 percent of cases. The post Inhaled Drug Could Treat Rare Cystic Fibrosis Mutations appeared first on Zenger News.
via Bing News